Eli Lilly Raises Revenue Forecast as Shares Surge
Higher revenue guidance offsets weaker-than-expected results for its weight-loss injections and Foundayo.
Higher revenue guidance offsets weaker-than-expected results for its weight-loss injections and Foundayo.